Implanet reports 20% Q3 revenue growth: 5 things to know

Laura Dyrda -   Print  | Email

Implanet reported third quarter revenue grew 20 percent year-over-year.

Here are five things to know:


1. Spine revenue jumped 23 percent in the third quarter while knee and arthroscopy revenue dropped 12 percent overall.


2. Jazz spinal implant sales reported a 30 percent growth in the third quarter, and sales were up around 23 percent for the first nine months of the year. Jazz revenue currently accounts for 62 percent of the total revenue.


3. In France, Jazz sales climbed 10 percent while in the rest of the world Jazz sales were up 159 percent in the third quarter. U.S. Jazz sales jumped 12 percent for the quarter after the company partnered with larger players in the market.


4. The company sold 1,655 Jazz implants in the third quarter and 6,296 in the first nine months of 2017.


5. Implanet has signed new commercial partnerships in the U.S. to accelerate technology penetration and recruit new surgeons.


More articles on orthopedic devices:
K2M adjusts projected 2017 revenue down after hurricanes soften Q3 sales
DePuy Synthes, Stryker, Zimmer Biomet & more: 13 device company key notes
1st Ohio hospital implements Synaptive Medical's BrightMatter technology

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.